271 related articles for article (PubMed ID: 7589702)
21. Differential manipulation of normal and chronic myeloid leukemia stem cell proliferation in vitro.
Eaves C; Eaves A
Blood Cells; 1994; 20(1):83-93; discussion 93-5. PubMed ID: 7994064
[TBL] [Abstract][Full Text] [Related]
22. Severe functional alterations in vitro in CD34(+) cell subpopulations from patients with chronic myeloid leukemia.
Chávez-González A; Rosas-Cabral A; Vela-Ojeda J; González JC; Mayani H
Leuk Res; 2004 Jun; 28(6):639-47. PubMed ID: 15120942
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms mediating the inhibitory effect of all-trans retinoic acid on primitive hematopoietic stem cells in human long-term bone marrow culture.
Sammons J; Ahmed N; Khokher MA; Hassan HT
Stem Cells; 2000; 18(3):214-9. PubMed ID: 10840075
[TBL] [Abstract][Full Text] [Related]
24. Membrane protein hMYADM preferentially expressed in myeloid cells is up-regulated during differentiation of stem cells and myeloid leukemia cells.
Wang Q; Li N; Wang X; Shen J; Hong X; Yu H; Zhang Y; Wan T; Zhang L; Wang J; Cao X
Life Sci; 2007 Jan; 80(5):420-9. PubMed ID: 17097684
[TBL] [Abstract][Full Text] [Related]
25. Expression of nuclear envelope lamins A and C in human myeloid leukemias.
Kaufmann SH
Cancer Res; 1992 May; 52(10):2847-53. PubMed ID: 1581898
[TBL] [Abstract][Full Text] [Related]
26. Differentiation of myeloid cells in liquid culture: 2. Acute myelocytic leukemia cells.
Archimbaud E; Preisler HD
Cell Biochem Funct; 1987 Jul; 5(3):157-66. PubMed ID: 3475187
[TBL] [Abstract][Full Text] [Related]
27. Leukemia inhibitory factor in long-term adherent layer cultures: increased levels of bioactive protein in leukemia and modulation by IL-4, IL-1 beta, and TNF-alpha.
Wetzler M; Estrov Z; Talpaz M; Kim KJ; Alphonso M; Srinivasan R; Kurzrock R
Cancer Res; 1994 Apr; 54(7):1837-42. PubMed ID: 8137298
[TBL] [Abstract][Full Text] [Related]
28. Extensive amplification of single cells from CD34+ subpopulations in umbilical cord blood and identification of long-term culture-initiating cells present in two subsets.
de Wynter EA; Nadali G; Coutinho LH; Testa NG
Stem Cells; 1996 Sep; 14(5):566-76. PubMed ID: 8888497
[TBL] [Abstract][Full Text] [Related]
29. Modulation of cell surface antigens induced by 12-O-tetradecanoyl-phorbol 13-acetate in two myeloblastic cell lines, a promyelocytic cell line, and a monoblastic cell line: detection with five monoclonal antibodies.
Sugimoto T; Tatsumi E; Takeda K; Minato K; Sagawa K; Minowada J
J Natl Cancer Inst; 1984 Apr; 72(4):923-8. PubMed ID: 6368942
[TBL] [Abstract][Full Text] [Related]
30. Potent antileukemic activity of the novel agents norsegoline and dibezine.
Einat M; Nagler A; Lishner M; Amiel A; Yarkoni S; Rudi A; Gellerman G; Kashman Y; Fabian I
Clin Cancer Res; 1995 Aug; 1(8):823-9. PubMed ID: 9816051
[TBL] [Abstract][Full Text] [Related]
31. Interferon-alpha-treated patients with chronic myelogenous leukemia show BCR/ABL-positive peripheral blood progenitor cells surviving long-term culture.
Schultheis B; Heissig B; Pasternak G; Hörner S; Hehlmann R
Folia Biol (Praha); 2000; 46(6):251-5. PubMed ID: 11140858
[TBL] [Abstract][Full Text] [Related]
32. Deficiency of a phosphatidylinositol-anchored cell adhesion molecule influences haemopoietic progenitor binding to marrow stroma in chronic myeloid leukaemia.
Gordon MY; Atkinson J; Clarke D; Dowding CR; Goldman JM; Grimsley PG; Siczkowski M; Greaves MF
Leukemia; 1991 Aug; 5(8):693-8. PubMed ID: 1715960
[TBL] [Abstract][Full Text] [Related]
33. Distribution of the 124-kd antigen defined by monoclonal antibody AML-1-99 on normal and leukemic myeloid cells.
Howell AL; Miller R; Keefe KA; McIntyre OR; Stockner M; Sullivan R; Hibbert SR; Noelle RJ; Ball ED
Exp Hematol; 1988 Mar; 16(3):176-83. PubMed ID: 3422192
[TBL] [Abstract][Full Text] [Related]
34. Long-term bone marrow culture induces terminal differentiation of human myeloid leukemic cells.
Iland HJ; Croaker GM; Repka E; Radloff TJ; Vincent PC
Exp Hematol; 1987 Dec; 15(11):1109-14. PubMed ID: 3479335
[TBL] [Abstract][Full Text] [Related]
35. Human monoclonal antibodies reactive with human myelomonocytic leukemia cells.
Posner MR; Santos DJ; Elboim HS; Tumber MB; Frackelton AR
Cancer Res; 1989 Apr; 49(7):1665-70. PubMed ID: 2924315
[TBL] [Abstract][Full Text] [Related]
36. Stimulation of proliferation and differentiation of acute myeloid leukemia cells on a bone marrow stroma in culture.
Schölzel C; Löwenberg B
Exp Hematol; 1985 Aug; 13(7):664-9. PubMed ID: 3861327
[TBL] [Abstract][Full Text] [Related]
37. Expression of alpha IIb beta 3 integrin (GPIIb-IIIa) in myeloid cell lines and normal CD34+/CD33+ bone marrow cells.
Wall CD; Conley PB; Armendariz-Borunda J; Sudarshan C; Wagner JE; Raghow R; Jennings LK
Blood Cells Mol Dis; 1997 Dec; 23(3):361-76. PubMed ID: 9398537
[TBL] [Abstract][Full Text] [Related]
38. Expression of CD56/NCAM on hematopoietic malignant cells. A useful marker for acute monocytic and megakaryocytic leukemias.
Ikushima S; Yoshihara T; Matsumura T; Misawa S; Morioka Y; Hibi S; Imashuku S
Int J Hematol; 1991 Oct; 54(5):395-403. PubMed ID: 1721853
[TBL] [Abstract][Full Text] [Related]
39. Bone marrow fibroblasts-conditioned medium regulates the proliferation of leukemic cells.
Kubota T; Nagao T; Arimori S
Tokai J Exp Clin Med; 1988 Feb; 13(1):45-51. PubMed ID: 3232161
[TBL] [Abstract][Full Text] [Related]
40. Adhesive interactions of normal and leukemic human CD34+ myeloid progenitors: role of marrow stromal, fibroblast, and cytomatrix components.
Liesveld JL; Winslow JM; Kempski MC; Ryan DH; Brennan JK; Abboud CN
Exp Hematol; 1991 Jan; 19(1):63-70. PubMed ID: 1703495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
